Results 251 to 260 of about 163,944 (309)

Exoscopic Extraforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disease: Technical Considerations and Clinical Outcomes During the Early Learning Curve. [PDF]

J Clin Med
Yamane K, Takao S, Sasaki K, Narita W, Shitozawa H, Takeuchi K, Nakahara S.   +6 more
europepmc   +1 more source

AB-Flu nanodrug combined with exercise intervention enhances ROS-mediated antitumor effects in melanoma. [PDF]

Front Physiol
Zhou Y, Ma J, Zhang Z, Niu X, Yan H, Zhang J.   +5 more
europepmc   +1 more source

Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study. [PDF]

Hum Vaccin Immunother
Leroux-Roels I, De Coster I, Borobia AM, Langley JM, Ochoa Mazarro D, Ruiz-Antorán B, Berrè S, Germain S, Knauer C, Koch SD, Mann P, Mesia Vela D, Ovbude LJ, Pardo IA, Srivastava B, Moldt B, Nordgren M.   +16 more
europepmc   +1 more source

Human-Generative AI Interactions and Their Effects on Beliefs About Health Issues: Content Analysis and Experiment. [PDF]

JMIR AI
Lu L, Wang YS, Liu J, McLeod DM.
europepmc   +1 more source

The Sigma-1 Receptor Agonist Fluvoxamine Is Protective in Hyperglycaemia-Induced Dysfunction of Trabecular Meshwork Cells. [PDF]

Pharmaceuticals (Basel)
Rozsahegyi A, Cserhalmi M, Medveczki T, Buzogany Z, Ruisanchez E, Budai A, Besztercei B, Szabo AJ, Hodrea J, Fekete A.   +9 more
europepmc   +1 more source

Fluvalinate accumulation in the beehive environment and its effects on semen quality and gene expression of drones under field conditions. [PDF]

Ecotoxicology
Ratvaj M, Staroň M, Sabo R, Kňazovická V, Cingeľová Maruščáková I, Mudroňová D, Maďar M, Staroňová D, Sabová L, Majchrák T.   +9 more
europepmc   +1 more source

Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026.

MMWR Morb Mortal Wkly Rep
Maloney P, Reeves EL, Wielgosz K, Price AM, Natarajan K, DeSilva MB, Dascomb K, Klein NP, Tartof SY, Irving SA, Grannis SJ, Ong TC, Weber ZA, Schuster JE, Zerr DM, Michaels MG, Boom JA, Halasa NB, Staat MA, Weinberg GA, House SL, Saade EA, Geffel KM, Gaglani M, Wernli KJ, Murugan V, Martin ET, Bontrager NAB, Kirby MK, Payne AB, Dawood FS, Tannis A, Moline HL, Zhao SK, Adams K, DeCuir J, Olson SM, Chung JR, Lewis N, Flannery B, Reed C, Garg S, Ellington S, CDC Influenza Vaccine Effectiveness Collaborators, CDC Influenza Vaccine Effectiveness Collaborators.   +44 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Spanish flu

Presse Medicale, 2022
The Spanish flu occurred at the end of the First world war, in disastrous epidemiological conditions on populations exhausted by four years of war. At that time, there were no vaccines, no antibiotics, no oxygen and no resuscitation. It was even thought that the infectious agent was a bacterium.
Patrick Berche
exaly   +3 more sources

The virologist and the flu

Journal of Clinical Virology, 2015
We report a case of a virologist - who is in age-appropriate medical condition with no relevant chronic diseases - who shed influenza A H3N2 virus RNA for 70 days while infectious virus could be detected by cell culture only up to 5 days after onset of symptoms despite a 5-day course of oseltamivir.
Sabine, Wicker, Holger F, Rabenau
openaire   +2 more sources